SGLT2抑制剂-话题@MedSci

#SGLT2抑制剂#

1篇内容 | 1508人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2179794, encodeId=59c921e979400, content=<a href='/topic/show?id=bdb75352116' target=_blank style='color:#2F92EE;'>#慢性心衰#</a> <a href='/topic/show?id=5f5f508933f' target=_blank style='color:#2F92EE;'>#心功能#</a> <a href='/topic/show?id=7c2616228bc' target=_blank style='color:#2F92EE;'>#SGLT2抑制剂#</a>, objectTitle=Cardiovasc Diabetol：SGLT2抑制剂对慢性心衰患者心功能和健康状况的影响, objectType=article, longId=808567, objectId=b6dd80856e8e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240106/1704550439252_1739456.jpg, objectUrl=/article/show_article.do?id=b6dd80856e8e, replyNumber=0, likeNumber=23, createdTime=2024-01-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b6dd80856e8e, moduleTitle=Cardiovasc Diabetol：SGLT2抑制剂对慢性心衰患者心功能和健康状况的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6dd80856e8e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170743, encodeId=524621e07436e, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=7c2616228bc' target=_blank style='color:#2F92EE;'>#SGLT2抑制剂#</a>, objectTitle=成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批, objectType=article, longId=801915, objectId=762080191506, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867668820_4754896.png, objectUrl=/article/show_article.do?id=762080191506, replyNumber=0, likeNumber=27, createdTime=2023-11-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=762080191506, moduleTitle=成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762080191506)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1242683, encodeId=e71f124268322, content=<a href='/topic/show?id=7c2616228bc' target=_blank style='color:#2F92EE;'>#SGLT2抑制剂#</a>在<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>患者中的当代应用情况, objectTitle=Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况, objectType=article, longId=736137, objectId=47e3e3613704, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220817/1660722037901_2467676.JPG, objectUrl=/article/show_article.do?id=47e3e3613704, replyNumber=0, likeNumber=86, createdTime=2022-09-02, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e3e3613704, moduleTitle=Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e3e3613704)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

SGLT2抑制剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性心衰# #心功能# #SGLT2抑制剂#

Cardiovasc Diabetol：SGLT2抑制剂对慢性心衰患者心功能和健康状况的影响

2024-01-07发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #SGLT2抑制剂#

成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批

2023-11-24发表于上海

(审核中...)

前往app查看评论内容

#SGLT2抑制剂#在#糖尿病#合并#心力衰竭#患者中的当代应用情况

Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况

2022-09-02

科室
- - 订阅+
  - 更多科室
工具
服务